Abstract:The aim of this study is to evaluate the diagnostic value of genome sequencing in children with epilepsy, and to provide genome sequencing-based insights into the molecular genetic mechanisms of epilepsy to help establish accurate diagnoses, design appropriate treatments and assist in genetic counselling. We performed genome sequencing on 320 Chinese children with epilepsy, and interpreted single-nucleotide variants and copy number variants of all samples. The complete pedigree and clinical data of the probands were established and followed up. The clinical phenotypes, treatments, prognoses and genotypes of the patients were analysed. Age at seizure onset ranged from 1 day to 17 years, with a median of 4.3 years. Pathogenic/likely pathogenic variants were found in 117 of the 320 children (36.6%), of whom 93 (29.1%) had single-nucleotide variants, 22 (6.9%) had copy number variants and two had both single-nucleotide variants and copy number variants. Single-nucleotide variants were most frequently found in SCN1A (10/95, 10.5%), which is associated with Dravet syndrome, followed by PRRT2 (8/95, 8.4%), which is associated with benign familial infantile epilepsy, and TSC2 (7/95, 7.4%), which is associated with tuberous sclerosis. Among the copy number variants, there were three with a length 525 kilobases. The most common recurrent copy number variants were 17p13.3 deletions (5/24, 20.8%), 16p11.2 deletions (4/24, 16.7%), and 7q11.23 duplications (2/24, 8.3%), which are associated with epilepsy, developmental retardation and congenital abnormalities. Four particular 16p11.2 deletions and two 15q11.2 deletions were considered to be susceptibility factors contributing to neurodevelopmental disorders associated with epilepsy. The diagnostic yield was 75.0% in patients with seizure onset during the first postnatal month, and gradually decreased in patients with seizure onset at a later age. Forty-two patients (13.1%) were found to be specifically treatable for the underlying genetic cause identified by genome sequencing. Three of them received corresponding targeted therapies and demonstrated favourable prognoses. Genome sequencing provides complete genetic diagnosis, thus enabling individualized treatment and genetic counselling for the parents of the patients. Genome sequencing is expected to become the first choice of methods for genetic testing of patients with epilepsy.

Genetic Diagnosis Spectrum and Multigenic Burden of Exome-Level Rare Variants in a Childhood Epilepsy Cohort

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing

Clinical and Genetic Spectrum of a Large Cohort of Children with Epilepsy in China

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Genetic and Phenotype Analysis of a Chinese Cohort of Infants and Children With Epilepsy

Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy

Genotype and Phenotype Analysis Using an Epilepsy‐associated Gene Panel in Chinese Pediatric Epilepsy Patients

Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy

High Genetic Burden in 163 Chinese Children with Status Epilepticus

Next Generation Sequencing in Children with Unexplained Epilepsy: A Retrospective Cohort Study.

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Genetic diagnoses in pediatric patients with epilepsy and comorbid intellectual disability.

Gene Mutational Analysis in a Cohort of Chinese Children with Unexplained Epilepsy: Identification of a New KCND3 Phenotype and Novel Genes Causing Dravet Syndrome

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes

Genome sequencing of 320 Chinese children with epilepsy: a clinical and molecular study

Identification of genetic causes in children with unexplained epilepsy based on trio‐whole exome sequencing

Epilepsies of presumed genetic etiology show enrichment of rare variants that occur in the general population

Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients

Genetic Spectrum Identified by Exome Sequencing in a Chinese Pediatric Cerebral Palsy Cohort

Next-generation sequencing testing in children with epilepsy reveals novel clinical, diagnostic and therapeutic implications